Review of T-cell activation: Impact of Janus kinase 3 inhibition

Transplantation

Volumn 75, Issue 11, 2003, Pages 1783-1785

  Nashan, Bjorn ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN; CYCLOSPORIN A; ENZYME INHIBITOR; EVEROLIMUS; INTERLEUKIN 2 RECEPTOR; JANUS KINASE; JANUS KINASE 3 INHIBITOR; RAPAMYCIN; STAT5 PROTEIN; T LYMPHOCYTE RECEPTOR; TACROLIMUS; UNCLASSIFIED DRUG; WHI P 154;

ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; CELL PROLIFERATION; IMMUNOSUPPRESSIVE TREATMENT; NATURAL KILLER CELL; NOTE; ORGAN TRANSPLANTATION; PARACRINE SIGNALING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE ACTIVATION;

HUMANS; JANUS KINASE 3; LYMPHOCYTE ACTIVATION; PROTEIN-TYROSINE KINASES; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY;

EID: 0038046342     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000066241.12823.C1     Document Type: Note

References (5)

1. Suthanthiran M, Strom T. Renal transplantation. N Engl J Med 1994; 331: 365.
2. Leonard WJ. Type I cytokines and interferons and their receptors. In: Paul WE, ed. Fundamental immunology [ed 4]. Philadelphia, Lippincott-Raven 1999, p 741.
3. Leonard WJ, Lin JX. Cytokine receptor signaling pathways. J Allergy Clin Immunol 2000; 105: 877.
4. Saemann MD, Zeyda M, Diakos C, et al. Suppression of early T-cell receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154. Transplantation 2003; 75: XXX.
5. Buckley RH. Advances in the understanding and treatment of human severe combined immunodeficiency. Immunol Res 2000; 22: 237.